Patents by Inventor Carol Ann Lange

Carol Ann Lange has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL
    Publication number: 20210132069
    Abstract: A method that includes testing for the presence of a phosphorylated Ser294 (phospho-Ser294) progesterone receptor (PR). A method that includes determining the expression level of a gene in a patient sample and comparing it to a control sample.
    Type: Application
    Filed: January 12, 2021
    Publication date: May 6, 2021
    Inventors: Carol Ann Lange, Todd P. Knutson
  • Methods of detecting progesterone receptor and of detecting an expression level
    Patent number: 10942183
    Abstract: A method that includes testing for the presence of a phosphorylated Ser294 (phospho-Ser294) progesterone receptor (PR). A method that includes determining the expression level of a gene in a patient sample and comparing it to a control sample.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: March 9, 2021
    Assignee: Regents of the University of Minnesota
    Inventors: Carol Ann Lange, Todd P. Knutson
  • Breast cancer prognosis
    Patent number: 10501800
    Abstract: The present invention provides gene expression profiles indicative of whether a patient afflicted with PR driven malignancies is likely to be responsive to treatment with a therapeutic compound that is an anti-progestin. By identifying such responsiveness, a treatment provider may determine in advance those patients who would benefit from such treatment, as well as identify alternative therapies for non-responders. Also, provided are methods of using gene expression profiles and assays for identifying the presence of a gene expression profile in a patient.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 10, 2019
    Assignee: Regents of the University of Minnesota
    Inventors: Carol Ann Lange, Todd Philip Knutson, Jason Basil Nikas
  • METHODS OF DETECTING PROGESTERONE RECEPTOR AND OF DETECTING AN EXPRESSION LEVEL
    Publication number: 20180292409
    Abstract: A method that includes testing for the presence of a phosphorylated Ser294 (phospho-Ser294) progesterone receptor (PR). A method that includes determining the expression level of a gene in a patient sample and comparing it to a control sample.
    Type: Application
    Filed: April 5, 2018
    Publication date: October 11, 2018
    Inventors: Carol Ann Lange, Todd P. Knutson